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Utility of digital pulse oximetry in the screening of 
lower extremity arterial disease
Jung-Nam Kwon, Whan-Bong Lee 
Division of Vascular Surgery, Department of Surgery, Wonkwang University Sanbon Hospital, Wonkwang University College of 
Medicine, Gunpo, Korea
Purpose: The aim of this study was to evaluate screening methods in the lower extremities by measurement of the digital 
pulse oximetry (oxygen percent saturation [SpO2]) of toes for peripheral arterial disease (PAD). Methods: A prospective 
study was performed among 49 patients (98 limbs) with lower extremity arterial occlusive disease. We attempted to measure 
the ankle-brachial index (ABI), digital  pulse oximetry (SpO2), and computerized tomographic angiography (CTA). Patients 
were divided into three groups by the traditional Fontaine classification system by symptom and CTA criteria: 1) Critical 
limb ischemia (Fontaine III and IV), 2) Claudication; (Fontaine II), and 3) asymptomatic limbs (Fontaine I). Results: The sensi-
tivity, specificity, positive and negative predictive values between active treatment groups (group I and II; endovascular and 
open surgery) and conservative group (group III) are all statistically significant. ABI; 55.09%, 94%, 96.7%, 39.02% (R = 12.54, P 
＜  0.000) SpO2; 87.06%, 87.8%, 84.3%, 90% (R = 40.11, P ＜  0.000). Pre-SpO2 and pre-ABI all show statistically significant corre-
lation in group I vs. group II, symptomatic PAD (group I and II) vs. asymptomatic PAD (group III), and the total PAD 
comparison. The Pearson's correlation coefficient between SpO2 and ABI all show significant correlation in group II. 
Pre-SpO2 vs. Pre-ABI show strong positive correlation except asymptomatic group (group III). Conclusion: Digital pulse oxi-
metry can be a useful, simple, noninvasive screening device as well as ABI in PAD.
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INTRODUCTION
The ideal screening test for PAD would be inexpensive, 
non-invasive, accurate, and easily administered in the 
physician’s office. In the U.S., the number of adults af-
fected by peripheral arterial disease (PAD) is as large as 8 
million [1], and in Korea, 4.4% (50/1,150) is reported [2] in 
elderly men (≥65), a number expected to rise as the eld-
erly population grows. Individuals with PAD have a 
three- to four-fold increased risk of cardiovascular disease 
morbidity and mortality compared to individuals without 
PAD [1]. Early detection of PAD allows the implemen-
tation of an effective treatment, which has been shown to 
reduce the morbid-mortality of cardiovascular patients. 
Currently recommended are several non-invasive tests in-
clude pulse palpation, the ankle-brachial index (ABI), Utility of digital pulse oximetry in the screening of lower extremity arterial disease
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transcutaneous oxygen tension, color-doppler ultra-
sonography, computed tomographic angiography (CTA), 
Angiography, and magnetic resonance angiography. Pul-
se palpation is easy to perform but has interobserver 
variability. Dorsalis pedis is congenitally absent in 4 to 
12% of the population [3]. ABI measurement is simple, in-
expensive, painless, reproducible and can be easily per-
formed in a physician’s office. But, for early detection of 
PAD, the ABI may not be as sensitive as reported. Carter 
[4] reported that in patients with severe arterial stenosis on 
arteriography, the ABI was abnormal in 80%, but when on-
ly mild arterial stenosis was present, the ABI was low in 
only 50%. In prior work, we found that digital pulse oxi-
metry (oxygen percent saturation [SpO2]) performed with 
a standardized protocol in a pulmonary function labo-
ratory at the time of arterial blood analysis was a useful 
tool for detecting hypoxia. But previous investigations of 
pulse oximetry to diagnose lower extremity arterial dis-
ease have produced mixed results. Joyce et al. [5] reported 
that patients with PAD had significantly lower arterial 
oxygen saturation (SaO2) in the ischemic limbs. The SaO2 
improved after revascularization. Jawahar et al. [6] found 
that pulse oximetry had low sensitivity to detect PAD 
when compared with the ABI used as the reference test. 
The patients in these studies were suspected of having ar-
terial disease on clinical grounds, so pulse oximetry was 
not used as a screening test. The present study was under-
taken to prospectively evaluate digital pulse oximetry as a 
non-invasive screening test for PAD.
METHODS
We performed a prospective study of 49 patients (98 
limbs) with PAD referred for initial PAD evaluation to the 
hospital between August 2009 and October 2010. Demo-
graphic, clinical, and laboratory data were recorded. SpO2 
measurements were performed by clinic staff during the 
initial clinic evaluation by using a handheld Radical-7 
Signal Extraction Pulse oximeter (Masimo Co., Irvine, CA, 
USA) applied to the index finger and both great toes with 
the patient in the sitting or supine position at room air. If 
the SpO2 signal was not obtainable due to necrosis or loss, 
the next toe’s signal was used. And the SpO2 signal was 
compared to finger signals that have diminished due to 
other disease or condition such as severe COPD, cardiac 
failure, or room temperature. The ABI measurements 
were performed after the digital pulse oximetry measure-
ments using a Non-invasive Vascular Screening Device 
VP-1000 (Model BP 230 RPE II, OMRON Healthcare Co., 
Kyoto, Japan). Three-dimensional CT-angiography analy-
ses were performed for evaluation of stenosis and ob-
struction of the peripheral arteries of the lower 
extremities. The diagnosis of PAD was based on clinical 
and CTA criteria. The criteria used for identifying sig-
nificant arterial stenosis or obstruction lesions. Patients 
were divided into three groups by the traditional Fontaine 
classification system by symptoms and CTA criteria. : 1) 
Critical limb ischemia (CLI); ischemic rest pain and ische-
mic ulceration/necrosis (Fontaine III and IV) with sig-
nificant arterial disease; 2) Claudication; (Fontaine II) with 
significant arterial disease, and 3) asymptomatic limbs 
(Fontaine I). 
Statistical analysis
Analysis was performed using SPSS ver. 18 (IBM, New 
York, NY, USA). Group variables were compared using 
one-way analysis of variance with post hoc multiple com-
parisons assuming homogenous variance. Significance 
was set at P = 0.05. Comparisons between SpO2 and ABI 
employed Pearson correlation coefficients with two-tailed 
significance set at P = 0.05.
RESULTS 
A total of 98 limbs were studied on 49 patients with 
PAD. The clinical characteristics of the patients participat-
ing in the study are summarized in Table 1. The majority of 
patients were male (41/49) and the mean age was 68.2 ± 
12.4 years.
The screening tests were performed by digital pulse oxi-
metry and ABI, and then the diagnosis and treatment 
planning with CTA. Active treatment for symptomatic 
limbs was performed in group I and II as open surgery 
and/or endovascular intervention. Conservative treat-Jung-Nam Kwon and Whan-Bong Lee 
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Characteristic Value
No. of patients (limbs) 49 (98)
Age (yr) 68.2 ± 12.4
Duration (mo), mean (range) 8.2 ± 4.1 (1-14)
DM, n (%)    34 (69.4)
Current smoker, n (%)    32 (65.3)
Hypertension, n (%)    32 (65.3)
Known heart disease, n (%)      12 (24.48)
Hyperlipidemia   8 (16)
Others, n (%)
  Prostate cancer 3 (6)
  CRF 1 (2)
  Hypothyroidism 1 (2)
Amputation 7 (14%) (only in group I)
Treatment options, no. of limbs (%)
  Open surgery group 25 (25.5)
  Endovascular treatment 8 (8.2)
  Combined treatment 37 (37.8)
  Conservative treatment 28 (28.6)
DM, diabetes mellitus; CRF, chronic renal failure.
Table 1. Clinical characteristics of study subjects
Group
Pre-treatment Post-treatment
ABI SpO2 (%) ABI SpO2 (%)
I 0.37 ± 0.3     56.2 ± 40.8 0.95 ± 0.1 97.25 ± 4.5
II   0.8 ± 0.2  95.6 ± 7.4 1.05 ± 0.9 97.02 ± 4.5
III 1.05 ± 0.1 98.07 ± 1.8 1.04 ± 0.1   98.6 ± 1.2
I&II   0.62 ± 0.33  78.69 ± 33.5 0.92 ± 0.2 97.12 ± 4.5
P-value ＜0.000 ＜0.000 ＜0.000 ＜0.000
Total (98 limbs)   0.7 ± 0.3    83.8 ± 29.9 1.02 ± 0.6     97.5 ± 0.39
P-value ＜0.000 ＜0.000 0.815 0.254
Group I, acute ischemic limbs (31 limbs); group II, claudication limbs (41 limbs); group III, conservative limbs (26 limbs); group I&II, 
symptomatic limbs (72 limbs).
ABI, ankle-brachial index; SpO2, oxygen percent saturation. 
P-value is significant at the 0.05 level.
Table 2. Results of pre-treatment and post-treatment of SpO2 and the ABI
Group I vs. II Group I & II vs. III Total limbs
R P-value R P-value R P-value
Pre-ABI  0.637   0.000
a) 0.547  0.000
a) 0.747  0.000
a)




Post-ABI  0.061 0.609 0.024 0.814 0.054 0.597
Post-SpO2 -0.026 0.830 0.167 0.101 0.124 0.222
SpO2, oxygen percent saturation; ABI, ankle-brachial index. 
a)Correlation is significant at the 0.05 level (2-tailed).
Table 3. The correlation of SpO2 and the ABI between groups
ment for asymptomatic limbs was performed in group III 
as medication or observation. Most common lesion was 
identified in femoropopliteal arteries. The pre-treatment 
ABI (pre-ABI), post-treatment ABI (post-ABI), pre-treat-
ment SpO2 (pre-SpO2), and post-treatment SpO2 (post- 
SpO2) are listed in Table 2. PAD diagnostic criteria of ABI 
were less than 0.9 and SpO2 less than 95% was considered 
abnormal. The sensitivity, specificity, positive and neg-
ative predictive values of ABI were 100%, 60.46%, 76.38%, 
100% and Pearson chi-square is statistically significant (R 
= 11.77, P = 0.003). SpO2 were 44.4%, 96.1%, 96.9%, 38.4% 
and Pearson chi-square is not statistically significant (R = 
3.02, P = 0.082). However, the sensitivity, specificity, pos-
itive and negative values between active treatment groups 
(group I and II) and medication group are all statistically 
significant. ABI; 55.09%, 94%, 96.7%, 39.02% (R = 12.54, P 
＜  0.000) SpO2; 87.06%, 87.8%, 84.3%, 90% (R = 40.11, P ＜ 
0.000).















  R 0.383 0.032 -0.146 0.205
  P-value 0.033
a) 0.864 0.433 0.267
Group II
  R 0368 0.614 0.560 0.035






  R 0.175 0.595 0.196 -0.112
  P-value 0.391 0.001
a) 0.338 0.584
Group I&II
  R 0.291 0.151 -0.020 0.291
  P-value 0.000
a) 0.239 0.866 0.013
a)
Total
  R 0.624 0.281 0.030 0.303




SpO2, oxygen percent saturation; ABI, ankle-brachial index. 
a)Correlation is significant at the 0.05 level (2-tailed).
Table 4. The Pearson’s correlation coefficient (R) between SpO2and
the ABI 
ABI between group I vs. II, group I, II vs. III, and in total 
limbs; Correlations show statistical significance in pre- 
ABI and pre-SpO2. 
Table 4 and Fig. 1 demonstrates the Pearson’s correla-
tion coefficient (R) between SpO2 and the ABI; pre-ABI vs. 
pre-SpO2, pre-ABI vs. post-ABI, pre-SpO2 vs. post-SpO2, 
post-ABI vs. post-SpO2. Group I shows statistically strong 
correlation in pre-SpO2 vs. pre-ABI, group II in all compar-
isons of parameters, group III in only pre-ABI vs. 
post-ABI, group I,II; symptomatic groups in pre-SpO2 vs. 
pre-ABI and post-SpO2 vs. post-ABI, total groups in 
pre-SpO2 vs. pre-ABI, pre-ABI vs. post-ABI, and post- 
SpO2 vs. post-SpO2. 
DISCUSSION 
The purpose of this study was to analyze the usefulness 
of SpO2 of screening tests for PAD. Circumstances of dis-
covery include intermittent claudication or distal trophic 
lesions, but some subjects were asymptomatic, and the 
condition was detected during routine physical examina-
tion [7,8]. The non-invasive screening techniques are fast, 
easy to perform, inexpensive and can be used in a primary 
health care population. When screening a population of 
PAD, a high-sensitivity is important [9].
ABI is the most recommended non-invasive screening 
test for PAD. Recent publications reported that the interval 
between 0.9 and 1.10, currently taken as normal, may not 
be so [10]. Actually, an ABI ≤0.9 has been recommended 
by the American Heart Association [11]. Among well- 
trained technicians, its reliability has been excellent, and 
the validity of the test for stenosis of ≥50% in leg arteries 
is high (sensitivity of 90% and specificity of 98%) [12]. 
However, the sensitivity of the ABI test varied widely 
among previous published studies. ABI detection in dia-
betes and the elderly yielded lower sensitivity, 15 to 20% 
[13], 63% [14], 68% [15], 69.3% [16], and 70.6% [17], sug-
gesting that the test may be affected by diabetes status and 
aging. And Feigelson et al. [18] found that when they ex-
cluded patients with symptoms and signs of PAD, ABI val-
ues of less than 0.9 had a sensitivity of only 28.4%; and sug-
gested that the ABI seems less accurate as a screening test 
in patients without symptoms or sings of PAD.
Pulse oximetry measures peripheral blood hemoglobin 
SaO2. Low blood flow in an extremity produces lower 
SaO2 in the blood, a fact that vascular surgeons use to as-
sess patency of arterial reconstructions [19]. Joyce et al. [5] 
compared the ABI, pulse oximetry measurement of the 
toes, and transcutaneous oxygen tension measurement 
with the arteriographic appearance in patients suspected 
of having limb ischemia. They found that pulse oximetry 
correlated best with the arteriographic appearance. 
Jawahar et al. [6] studied patients between suspected PAD 
group and non-suspected PAD group. Pulse oximetry re-
sults were defined as abnormal if there was a decrease of 
more than 2% in saturation at the toe from the finger or a 
decrease of more than 2% on elevation of the foot by 12-in. 
When an ABI less than 0.9 was considered as PAD, pulse 
oximetry had a sensitivity of only 16% [14]. Pulse oximetry 
is a well-established method for non-invasive evaluation 
of arterial oxygenation. Numerous studies have found 
that pulse oximetry is accurate and reliable for screening 
for hepatopulmonary syndrome [20], congenital heart dis-
ease [21], diabetes [14,22,23], and sepsis [24].
In this study, we divided patients by symptomatic cri-
teria, not treatment modality, because recent publications Jung-Nam Kwon and Whan-Bong Lee 
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Fig. 1. (A) Pre-SpO2 vs. pre-ABI; Pearson’s correlation coefficient R = 0.624 (P ＜ 0.000) show strong correlation. (B) Pre-ABI vs. post-ABI; 
Pearson’s correlation coefficient R = 0.281 (P ＜ 0.005) show positive correlation but statistically significant. (C) Post-ABI vs. post-SpO2; 
Pearson’s correlation coefficient R = 0.030 (P = 0.770) show no correlation nor statistically significant. (D) Post-SpO2 vs. post-ABI; Pearson’s
correlation coefficient R = 0.303 (P = 0.02) show positive correlation but statistically significant. Pre-SpO2, pre-treatment oxygen percent 
saturation; Pre-ABI, pre-treatment ankle-brachial index; Post-ABI, post-treatment ankle-brachial index; Post-SpO2, post-treatment oxygen 
percent saturation.
reported no difference between endovascular treatment 
and open surgery in multi-level studies [25,26].
We compared the ABI, digital pulse oximetry measure-
ment of the toes, and CTA appearance in patients sus-
pected of PAD. An ABI less than 0.9 was considered as 
PAD. The mean pre-ABI in total patients as compared to 
post-ABI were significantly lower (0.7 ± 0.3 vs. 1.02 ± 0.6; R 
= 0.09, P ＜  0.000) and show very high sensitivity and neg-
ative predictive values. In a survey of each group, post- 
ABI shows improvement compared to pre-ABI in group I 
and group II. I; Acute ischemic limbs 0.37 ± 0.3 vs. 0.95 ± 
0.1, II; Chronic limbs 0.8 ± 0.2 vs. 1.05 ± 0.9, III; Medication 
limbs 1.05 ± 0.1 vs. 1.04 ± 0.1 (R = 0.547, P ＜  0.000). In addi-
tion, the sensitivity and negative predictive values be-
tween active treatment groups (group I and II) and con-
servative group show the significant reduction (55.09%, 
39.02%, R = 12.54, P ＜  0.000). 
Pulse oximetry results were defined as abnormal if 
there was a decrease of more than 5% in saturation at the 
toe. The sensitivity, specificity, positive and negative pre-
dictive values of SpO2 are 44.4%, 96.1%, 96.9%, 38.4% and 
Pearson chi-square is not statistically significant (R = 3.02, Utility of digital pulse oximetry in the screening of lower extremity arterial disease
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P = 0.082). However, the sensitivity, specificity, positive 
and negative values of SpO2 between active treatment 
groups (group I and II) and conservative group are all stat-
istically significant (87.06%, 87.8%, 84.3%, 90%, R = 40.11, P 
＜  0.000). Overall, total patients show low sensitivity and 
negative predictive value of SpO2, whereas active treat-
ment groups for symptomatic limbs show even levels. 
In our study, the ABI and digital pulse oximetry meas-
urements of the toes before and after treatment (endovas-
cular treatment, open surgery, and medication) were 
compared. Group I vs. II, group I, II vs. III, and total PAD 
limbs show a significant difference at pre-SpO2 and 
pre-ABI. The Pearson’s correlation between SpO2 and ABI 
show strong correlation. In group I, acute ischemic limbs 
show in pre-SpO2 vs. pre-ABI. Group II, claudication 
limbs show the difference in all comparisons. Group I and 
II, symptomatic limbs show the correlation in pre-SpO2 vs. 
pre-ABI and post-SpO2 vs. post-ABI. 
Our results suggest that pulse oximetry is at least as ac-
curate as ABI and is an effective additional method for 
screening patients with PAD. 
In conclusion, these results suggest pulse oximetry may 
be a useful tool to screen for PAD in symptomatic patients.
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